Genetic Testing Market 2027 By Industry Players - 23andMe, Inc., Abbott Laboratories, Ambry Genetic, BGI, Biocartis Group NV

The genetic testing market is expected to witness lucrative growth driven by availability of different genetic tests for early and accurate disease diagnosis. Supportive regulatory framework by developed economies like U.S., Germany, UK, and France are favoring the adoption of genetic testing. Rising technological advancements and customer’s preference towards personalized medicines could create new growth opportunities in the industry. According to Global Market Insights, the genetic testing market size is expected to exceed USD 31.8 billion by 2027.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2490

Genetic testing has a varied range of applications in the field of cardiovascular disease, genetic disease, and cancer among others. Although, high cost associated with testing may hinder market expansion in the coming future. The direct-to-consumer genetic test could witness high demand among individuals globally. DTC genetic tests help in accessing the genetic information of customers without the need for involving any health insurance company or a healthcare provider in the process. Genetic tests help consumers to identify a genetic tendency to various diseases such as cancer, diabetes, and Alzheimer’s. Rising awareness regarding health safety may further boost market expansion.

Top industry players in the genetic testing industry include:

bioMérieux SA,
Abbott Laboratories,
23andMe, Inc., Ltd.,
BGI,
Ambry Genetics,
Biocartis Group NV,
Bio-Helix Co.,
Cepheid (Danaher Corporation),
Blueprint Genetics,
Eurofins Scientific
Request for customization @ https://www.gminsights.com/roc/2490

The genetic testing industry is categorized into cancer, genetic disease, and cardiovascular disease based on application. The cardiovascular disease application segment in particular is expected to be driven by rising cases of cardiovascular disorders throughout the world. Reports suggest that the cardiovascular segment was accounted for USD 1.4 billion in 2020 and is projected to grow considerably over the analysis timeline. Cardiovascular disease are said to be the leading cause of death across the globe, with around 85% of deaths being due to heart attack and stroke. Rise in such instances could elevate the demand for genetic tests. Early diagnosis of cardiovascular diseases can help improve the lives of people, resulting in high probability of surviving rate as well as reduced treatment cost.

Partial Chapter of the Table of Content

Chapter 4 Genetic Testing Market, By Test Type

4.1 Key segment trends

4.2 Predictive testing

4.2.1 Market size, by region, 2016 - 2027 (USD Million)

4.3 Carrier testing

4.3.1 Market size, by region, 2016 - 2027 (USD Million)

4.4 Prenatal and new-born testing

4.4.1 Market size, by region, 2016 - 2027 (USD Million)

4.5 Diagnostic testing

4.5.1 Market size, by region, 2016 - 2027 (USD Million)

4.6 Pharmacogenomic testing

4.6.1 Market size, by region, 2016 - 2027 (USD Million)

4.7 Nutrigenomic testing

4.7.1 Market size, by region, 2016 - 2027 (USD Million)

4.8 Others

4.8.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Genetic Testing Market, By Application

5.1 Key segment trends

5.2 Cancer

5.2.1 Market size, by region, 2016 - 2027 (USD Million)

5.3 Genetic diseases

5.3.1 Market size, by region, 2016 - 2027 (USD Million)

5.4 Cardiovascular disease

5.4.1 Market size, by region, 2016 - 2027 (USD Million)

5.5 Others

5.5.1 Market size, by region, 2016 - 2027 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/genetic-testing-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.